Filing Flows › Versigent (VGNT) › Q2 2026
Versigent (VGNT) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 4, 2026
Versigent (VGNT) reported revenue of $2.4B for the second quarter 2026 (Q2 2026), +11% from a year earlier and +10% from the quarter before. Operating margin was 8.1%, net earnings $118M (4.8% of revenue).
Versigent, Q2 2026: revenue $2.4B (+11% year over year), operating margin 8.1%, net earnings $118M, operating cash flow $158M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4B | +10% | +11% |
| Operating profit | $199M | +169% | +52% |
| Net earnings | $118M | +51% | +10% |
| Operating cash flow | $158M | +339% | +5% |
| Free cash flow | $107M | — | -0.9% |
What changed
Revenue was $2.4B in Q2 2026, up 11% year over year and up 10% from the previous quarter. Low Voltage Electrical Architecture was the largest line at 91% of revenue. Low Voltage Electrical Architecture added $0.28B year over year (up 14%), 116% of the total change. High Voltage Electrical Architecture declined 15%.
Operating profit was $0.20B, a 8.1% margin (up 2.2 points year over year). Of the extra revenue versus a year earlier, 29% reached operating profit, above the 6% margin then. Total costs grew 8% against revenue growth of 11%. Net earnings were $0.12B, up 10% year over year. The effective tax rate was 28.4%.
Operating cash flow was $0.16B (up 5% year over year), 136% of net earnings. Non-cash charges added back $0.05B of depreciation and amortization and $0.01B of share-based compensation. Working capital and other items used $0.02B. After capital expenditures ($0.05B), free cash flow as the company reports it was $0.11B.
Questions
What was Versigent's revenue in the second quarter 2026?
Versigent (VGNT) reported revenue of $2.4B for the second quarter 2026 (Q2 2026), +11% from a year earlier and +10% from the quarter before.
Was Versigent profitable in the second quarter 2026?
Operating profit was $199M (8.1% of revenue) and net earnings $118M.
Source: Versigent 10-Q on SEC EDGAR.